Ipamorelin 30mg — Vial Spec, Reconstitution Math & COA

Overview of the Ipamorelin 30mg Research Mass

A 30mg vial of Ipamorelin contains a high-density, lyophilized cake of the synthetic pentapeptide Aib-His-D-2-Nal-D-Phe-Lys-NH2. Designed primarily for high-throughput preclinical screening, automated multi-well cell assays, or long-term parallel animal models, the 30mg bulk mass allows research teams to prepare uniform stock solutions from a single manufacturing lot. This consistency minimizes lot-to-lot baseline variance during longitudinal receptor-binding studies.

Because Ipamorelin acts as a selective growth hormone secretagogue targeting the ghrelin/growth hormone secretagogue receptor (GHS-R1a), maintaining exact peptide concentration during reconstitution is critical. The 30mg format presents unique volumetric considerations for liquid handling systems and manual micro-pipetting due to the increased mass-to-volume ratio upon reconstitution.

Availability & Stocking Model: 30mg vs. Standard Laboratory Fills

PX1 Research maintains a strict quality control workflow regarding lyophilized peptide stability. While high-mass 30mg vials are occasionally requested for automated liquid-handling systems in industrial screeners, PX1 Research standard catalog offerings prioritize 2mg, 5mg, and 10mg vials. You can view our fully stock-ready inventory on the Ipamorelin product page or explore our complete all peptides catalog.

Smaller unit fill sizes are generally preferred in academic and institutional laboratories. Once a peptide cake is reconstituted in aqueous diluent, chemical stability degrades significantly faster over time than in its freeze-dried state. Distributing a total project allotment across multiple 5mg or 10mg vials prevents unnecessary freeze-thaw cycles and limits aqueous exposure degradation for the unused portion of the batch.

Reconstitution Mathematics for a 30mg Lyophilized Mass

Calculating working solution concentrations for a 30mg vial requires precise liquid volumetric math. Because 30,000 micrograms (mcg) of raw compound are present in the vial, adding low diluent volumes yields highly concentrated stock solutions. Researchers must ensure complete dissolution before transferring liquid aliquots.

Using standard laboratory diluents such as Bacteriostatic Water (0.9% Benzyl Alcohol) or Sterile Normal Saline, the resulting concentrations for common diluent volumes are calculated as follows: • **1.0 mL Diluent Volume:** Yields a final concentration of 30.0 mg/mL (30.0 mcg/µL). • **2.0 mL Diluent Volume:** Yields a final concentration of 15.0 mg/mL (15.0 mcg/µL). • **3.0 mL Diluent Volume:** Yields a final concentration of 10.0 mg/mL (10.0 mcg/µL). • **5.0 mL Diluent Volume:** Yields a final concentration of 6.0 mg/mL (6.0 mcg/µL). • **6.0 mL Diluent Volume:** Yields a final concentration of 5.0 mg/mL (5.0 mcg/µL).

For custom liquid-handling protocols or lower-mass vial calculations, researchers can utilize our interactive laboratory reconstitution calculator to determine exact micro-liter pipette volumes prior to assay execution.

Aliquot Planning and Long-Term Aqueous Storage Protocols

Reconstituting a 30mg vial creates a substantial volume of active liquid compound. Leaving large reconstituted volumes in a single glass vial for extended periods increases the risk of peptide aggregation, hydrophobic surface binding, and enzymatic or bacterial contamination. To maintain molecular fidelity, laboratories should implement an aliquot strategy immediately post-reconstitution.

Once fully dissolved in sterile diluent, the master solution should be partitioned into single-use micro-centrifuge tubes (e.g., 100 µL to 500 µL per tube) using low-protein-binding polypropylene vessels. Aliquots intended for immediate use within 24–72 hours may be held at 2°C to 8°C. For long-term storage, aliquots must be flash-frozen and preserved at -20°C or -80°C. Repeated freeze-thaw cycles must be strictly avoided, as thermal cycling causes peptide cleavage and precipitation.

Molecular Mechanism & Preclinical Selectivity Profile

Ipamorelin is classified as a selective ghrelin receptor agonist and growth hormone secretagogue (GHS). Preclinical in vitro assays and rodent models demonstrate that Ipamorelin binds specifically to the GHS-R1a receptor on pituitary somatotropes. Binding triggers a G-protein-coupled intracellular signaling cascade that induces pulsatile secretion of endogenous growth hormone (GH).

A key distinguishing feature of Ipamorelin in published literature is its exceptional selectivity. Unlike first- and second-generation GH secretagogues, in vitro cell studies demonstrate that Ipamorelin stimulates GH release without causing significant secondary elevation of adrenocorticotropic hormone (ACTH), cortisol, or prolactin. This narrow receptor activation spectrum makes it a highly valuable tool for isolation of GH-mediated cellular pathways without confounding glucocorticoid or lactotrophic signaling.

Comparative Analysis within the Secretagogue Class

When designing comparative secretagogue protocols, researchers frequently analyze Ipamorelin alongside other synthetic peptides targeting the GH axis. Understanding the structural and operational differences between these molecules ensures proper protocol selection.

While Ipamorelin is a pentapeptide acting exclusively at the GHS-R1a site, growth hormone releasing hormone (GHRH) analogs such as CJC-1295 Without DAC or Sermorelin bind to the distinct GHRH receptor. Older hexapeptides like GHRP-2 and GHRP-6 also target GHS-R1a but exhibit lower receptor selectivity, frequently triggering measured increases in plasma cortisol and prolactin levels in animal models. By contrast, Ipamorelin provides targeted somatotrope activation without activating secondary stress hormone cascades.

Quality Assurance: Lot-Matched COA, HPLC, and Endotoxin Standards

Due to the high peptide mass per unit in a 30mg vial, analytical verification is vital. Unidentified impurities or residual trifluoroacetic acid (TFA) salts can skew cellular assays or introduce cytotoxic variability into tissue culture media.

PX1 Research subjects every production lot to comprehensive analytical testing in an ISO 17025 accredited laboratory facility within the USA. Each lot receives a downloadable, lot-matched Certificate of Analysis containing: 1. **High-Performance Liquid Chromatography (HPLC):** Verifies chemical purity levels exceeding 99.0%. 2. **Mass Spectrometry (MS):** Confirms exact molecular mass (665.8 g/mol) and amino acid sequence identity. 3. **Endotoxin Testing (LAL Assay):** Ensures endotoxin levels remain below strictly controlled thresholds (<0.5 EU/mg) for cell culture safety.

Researchers can inspect authentic laboratory test results directly through our centralized COA verification hub.

Institutional Sourcing & Wholesale Research Protocols

Principal investigators, biotechnology laboratories, and academic institutions conducting large-scale screening studies require dependable supply chain logistics. PX1 Research operates GMP-compliant storage facilities in California and Arizona, providing rapid same-day dispatch (Monday through Friday) to support uninterrupted research schedules.

For custom fill requirements, bulk volume inquiries, or specialized institutional accounts, research directors are encouraged to submit procurement specifications through our dedicated wholesale research portal. Our technical team assists with batch matching, volume tiers, and custom packaging protocols designed specifically for high-throughput screening applications. Additional technical guides and compound documentation are accessible in our comprehensive research hub.